J MED BIOCHEM 润色咨询

Journal of Medical Biochemistry

出版年份：2007 年文章数：299 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：60.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2139122, encodeId=3282213912265, content=这期刊貌似注册不了，最近不能投了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cda38636866, createdName=ms8000000220690656, createdTime=Fri May 26 09:46:14 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575920, encodeId=73745e5920d4, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：Journal of Medical Biochemistry是塞尔维亚于2007年创办的季刊，由塞尔维亚医学生物化学学会发布，ISSN号为1452-8258，该期刊的主编是Nada Majki?-Singh。可能是Journal of Medical Biochemistry期刊的稿源并不充足，因此该期刊的刊文速度相当快，研究型论文平均1个月，综述类论文平均1周就能完成整个投稿过程。下面我们通过其上的文章来具体看看 自引超过50％，可能很危险了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104441, encodeId=1377110444163, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104442, encodeId=1fac1104442f9, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575921, encodeId=0a455e5921e9, content=国人投稿很少，冷门期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2023-05-26 ms8000000220690656 来自浙江省

    这期刊貌似注册不了，最近不能投了吧？

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2139122, encodeId=3282213912265, content=这期刊貌似注册不了，最近不能投了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cda38636866, createdName=ms8000000220690656, createdTime=Fri May 26 09:46:14 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575920, encodeId=73745e5920d4, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：Journal of Medical Biochemistry是塞尔维亚于2007年创办的季刊，由塞尔维亚医学生物化学学会发布，ISSN号为1452-8258，该期刊的主编是Nada Majki?-Singh。可能是Journal of Medical Biochemistry期刊的稿源并不充足，因此该期刊的刊文速度相当快，研究型论文平均1个月，综述类论文平均1周就能完成整个投稿过程。下面我们通过其上的文章来具体看看 自引超过50％，可能很危险了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104441, encodeId=1377110444163, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104442, encodeId=1fac1104442f9, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575921, encodeId=0a455e5921e9, content=国人投稿很少，冷门期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2019-09-06 lovetcm

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：Journal of Medical Biochemistry是塞尔维亚于2007年创办的季刊，由塞尔维亚医学生物化学学会发布，ISSN号为1452-8258，该期刊的主编是Nada Majki?-Singh。可能是Journal of Medical Biochemistry期刊的稿源并不充足，因此该期刊的刊文速度相当快，研究型论文平均1个月，综述类论文平均1周就能完成整个投稿过程。下面我们通过其上的文章来具体看看 自引超过50％，可能很危险了！

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2139122, encodeId=3282213912265, content=这期刊貌似注册不了，最近不能投了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cda38636866, createdName=ms8000000220690656, createdTime=Fri May 26 09:46:14 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575920, encodeId=73745e5920d4, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：Journal of Medical Biochemistry是塞尔维亚于2007年创办的季刊，由塞尔维亚医学生物化学学会发布，ISSN号为1452-8258，该期刊的主编是Nada Majki?-Singh。可能是Journal of Medical Biochemistry期刊的稿源并不充足，因此该期刊的刊文速度相当快，研究型论文平均1个月，综述类论文平均1周就能完成整个投稿过程。下面我们通过其上的文章来具体看看 自引超过50％，可能很危险了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104441, encodeId=1377110444163, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104442, encodeId=1fac1104442f9, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575921, encodeId=0a455e5921e9, content=国人投稿很少，冷门期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2021-12-27 rayms

    期刊可以有几个通讯作者/第一作者？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2139122, encodeId=3282213912265, content=这期刊貌似注册不了，最近不能投了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cda38636866, createdName=ms8000000220690656, createdTime=Fri May 26 09:46:14 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575920, encodeId=73745e5920d4, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：Journal of Medical Biochemistry是塞尔维亚于2007年创办的季刊，由塞尔维亚医学生物化学学会发布，ISSN号为1452-8258，该期刊的主编是Nada Majki?-Singh。可能是Journal of Medical Biochemistry期刊的稿源并不充足，因此该期刊的刊文速度相当快，研究型论文平均1个月，综述类论文平均1周就能完成整个投稿过程。下面我们通过其上的文章来具体看看 自引超过50％，可能很危险了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104441, encodeId=1377110444163, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104442, encodeId=1fac1104442f9, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575921, encodeId=0a455e5921e9, content=国人投稿很少，冷门期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2021-12-27 Mia

    所有作者在文章接收之后都会接收到邮件吗？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2139122, encodeId=3282213912265, content=这期刊貌似注册不了，最近不能投了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cda38636866, createdName=ms8000000220690656, createdTime=Fri May 26 09:46:14 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575920, encodeId=73745e5920d4, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：Journal of Medical Biochemistry是塞尔维亚于2007年创办的季刊，由塞尔维亚医学生物化学学会发布，ISSN号为1452-8258，该期刊的主编是Nada Majki?-Singh。可能是Journal of Medical Biochemistry期刊的稿源并不充足，因此该期刊的刊文速度相当快，研究型论文平均1个月，综述类论文平均1周就能完成整个投稿过程。下面我们通过其上的文章来具体看看 自引超过50％，可能很危险了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104441, encodeId=1377110444163, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104442, encodeId=1fac1104442f9, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575921, encodeId=0a455e5921e9, content=国人投稿很少，冷门期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2019-09-06 lovetcm

    国人投稿很少，冷门期刊

    0

共11条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分